Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Generics share of prescription spending in the U.S. by formulation 2012 vs. 2017

Generics share of total prescription drugs spending in the U.S. by formulation in 2012 and 2017

by Matej Mikulic, last edited Jun 12, 2018
Generics share of prescription spending in the U.S. by formulation 2012 vs. 2017 This statistic depicts the generics share of total spending on prescription drugs in 2012 and 2017 in the U.S., by formulation. Among drugs categorized as oral solids by formulation, generics accounted for 18.3 percent of spending in 2017 and 20.8 percent of spending in 2012.
Show more

Generics share of total prescription drugs spending in the U.S. by formulation in 2012 and 2017

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.